Press Releases

With 97 percent of all drug discovery programs failing, the development of a single new therapeutic involves an average cost of $2.6 billion. The complex industry/academia/government research framework involved in the discovery and development of new therapeutic products makes drug discovery an extremely laborious process.

Sensors play a central role in a digital ecosystem, particularly the use of micro- and nano-sensors that can detect a host of biological, organic and inorganic substances, and communicate their detection to a smartphone or a communication system in real time. The ecosystem would enable a seamless digital world in which particulate matter,

Philips Recognized by Frost & Sullivan for Its Integrated Medication Adherence System, PMAS  By connecting patients, pharmacists, caregivers, and providers, the PMAS delivers patient care in a decentralized format SANTA CLARA, Calif. — December 5, 2018 — Based on...

Optum Earns Acclaim from Frost & Sullivan for Leading the Population Health Management Market with Its Integrated Technology Platforms and Services  Optum improves care coordination, patient engagement and total cost of care; Makes it a valued partner for health...

Frost & Sullivan has co-organised with AMIP (Moroccan Pharmaceutical Industry Association) to host its very first Healthcare Meeting on December 4, 2018 at the Hyatt Regency Hotel, Casablanca, Morocco.

Stringent regulations and a heightened need for faster, more effective, and less expensive surgeries are creating tremendous growth opportunities for global biomedical adhesives and sealants. Furthermore, increasing technology adoption rates and rising healthcare expenditure in the Asia-Pacific region will augment growth prospects.

Based on its recent analysis of the European rhinitis therapy market, Frost & Sullivan recognises Neurent Medical with the 2018 European New Product Innovation Award for developing a non-surgical, minimally invasive device that uses radio frequency (RF) to modulate a nerve group to offer relief from nasal obstruction and rhinorrhea.

Numerous pharmaceuticals are turning to biologics contract development and manufacturing organizations (CDMOs) for both clinical- and commercial-stage manufacturing in order to deal with the growing demand for biologics and biosimilars, the capital-intensive nature of the business, and the complex manufacturing requirements.

The high resolution and sensitivity of tandem liquid chromatography-mass spectrometry (LC-MS) and time of flight (TOF) LC-MS are expanding the application scope of mass spectrometers.

Based on its recent analysis of the European non-invasive respiratory monitoring market, Frost & Sullivan recognises PMD Solutions with the 2018 European Visionary Innovation Leadership Award for its forward-looking wearable respiratory rate (RR) monitoring solution

Based on its recent analysis of the North America diagnostic cardiology market, Frost & Sullivan recognizes Welch Allyn, a subsidiary of Hill-Rom, with the 2018 North America Technology Innovation Award for its industry-leading and clinically validated cardiology solutions.

프로스트 앤 설리번 한국지사는 금일 11월 1일 오전 코엑스에서 Global & APAC Medical Device Outlook 2019 브리핑을 개최했다. 

Frost & Sullivan, the growth partnership company, announced today that it will host a live, complimentary Growth Innovation Leadership (GIL) briefing titled, “2019 Healthcare Predictions Unleashed – Growth Opportunities, Technology, and Trends,” 

Frost & Sullivan, the growth partnership company, announced today that it will host a live, complimentary Growth Innovation Leadership (GIL) briefing titled, “Medical Marijuana Market Trends – Future Clinical Role of Medical Marijuana & CBD,” on Tuesday, October 30, 2018